Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous dexmedetomidine, Apotel (intravenous paracetamol), and Apodex combination for prevention of postoperative emergence agitation and pain after adenotonsillectomy
IRCT2016092930049N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and acetaminophen in postoperative pain and Emergence agitation (EA), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: postoperative emergence agitation and postoperative pain. Started Apr 2017; status: completed.
02
Drugs
dexmedetomidineacetaminophen
03
Conditions
postoperative painEmergence agitation (EA)
Beyond the preview
Go deeper on IRCT2016092930049N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016092930049N1.